Results 21 to 30 of about 106,721 (360)

Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis

Science Translational Medicine, 2022
Immune-mediated bile duct epithelial injury and toxicity of retained hydrophobic bile acids drive disease progression in fibrosing cholangiopathies such as biliary atresia or primary sclerosing cholangitis.
Tiffany Shi, Astha Malik, Annika Yang vom Hofe, Louis Matuschek, M. Mullen, Celine S. Lages, Ramesh Kudira, Ruchi Singh, Wujuan Zhang, K. Setchell, D. Hildeman, C. Pasare, B. Wagner, A. Miethke   +13 more
semanticscholar   +1 more source

Primary sclerosing cholangitis

Best Practice & Research Clinical Gastroenterology, 2010
Primary sclerosing cholangitis (PSC) is a chronic bile duct disease leading to fibrotic biliary strictures and liver cirrhosis. The patient population is heterogeneous with regard to disease progression and the presence of co-morbidities, complicating the practical handling of patients as well as studies of pathogenetic mechanisms. The aetiology of PSC
Tom H, Karlsen, Erik, Schrumpf, Kirsten Muri, Boberg   +2 more
  +7 more sources

Primary sclerosing cholangitis – a comprehensive review

Journal of Hepatology, 2017
Tom H Karlsen, Trine Folseraas
exaly   +2 more sources

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis

Abdominal Radiology, 2022
Sclerosing cholangitis is a chronic cholestatic disease characterized by stricturing, beading, and obliterative fibrosis of the bile ducts. Sclerosing cholangitis is considered primary (PSC) if no underlying etiology is identified or secondary (SSC) if ...
D. Ludwig, Mark A. Anderson, M. Itani, Kedar G. Sharbidre, N. Lalwani, R. Paspulati   +5 more
semanticscholar   +1 more source

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports

Journal of Medical Case Reports, 2023
Background Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature.
Haythem Yacoub, Sarra Ben Azouz, Hajer Hassine, Habiba Debbabi, Dhouha Cherif, Feriel Ghayeb, Seif Boukriba, Héla Kchir, Nadia Maamouri   +8 more
doaj   +1 more source

Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020

Journal of hepato-biliary-pancreatic sciences, 2021
Several years have passed since the clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then.
T. Nakazawa, T. Kamisawa, K. Okazaki, S. Kawa, S. Tazuma, T. Nishino, D. Inoue, I. Naitoh, Takayuki Watanabe, K. Notohara, K. Kubota, H. Ohara, A. Tanaka, H. Takikawa, A. Masamune, Tosiaki Unno   +15 more
semanticscholar   +1 more source

The natural history of primary sclerosing cholangitis in 781 children. A multicenter, international collaboration [PDF]

, 2017
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long-term outcomes of pediatric PSC.
Abdou, Reham, Alqoaer, Khaled, Amin, Mansi, Amir, Achiya Z, Auth, Marcus, Bazerbachi, Fateh, Broderick, Annemarie, Chan, Albert, Cotter, Jillian, Deneau, Mark R, Doan, Sylvia, El-Matary, Wael, El-Youssef, Mounif, Ferrari, Federica, Furuya, Katryn N, Gottrand, Frederic, Gottrand, Madeleine, Gupta, Nitika, Homan, Matjaz, Iorio, Raffaele, Jensen, M K, Kamath, Binita M, Kolho, Kaija-Leena, Konidari, Anastasia, Koot, Bart, Ledder, Oren, Mack, Cara, Martinez, Mercedes, Miloh, Tamir, Mo Kim, Kyung, Mohan, Parvathi, O'Cathain, Niamh, Papadopoulou, Alexandra, Ricciuto, Amanda, Sathya, Pushpa, Saubermann, Lawrence, Shteyer, Eyal, Smolka, Vratislav, Tanaka, Atushi, Valentino, Pamela L, Varier, Raghu, Venkat, Veena, Vitola, Bernadette, Vos, Miriam B, Woynarowski, Marek, Yap, Jason   +45 more
core   +6 more sources

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile

Hepatology, 2021
Primary sclerosing cholangitis (PSC) is associated with increased risk of cholangiocarcinoma (CCA). Early and accurate CCA detection represents an unmet clinical need as the majority of patients with PSC are diagnosed at an advanced stage of malignancy ...
H. M. Vedeld, Marit M. Grimsrud, K. Andresen, H. Pharo, Erik von Seth, T. Karlsen, H. Honne, V. Paulsen, M. Färkkilä, A. Bergquist, M. Jeanmougin, L. Aabakken, K. Boberg, T. Folseraas, G. E. Lind   +14 more
semanticscholar   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report

World Journal of Surgical Oncology, 2018
Background Diagnostic work-ups in transplanted immunosuppressed patients are a challenge as non-specific findings may be interpreted as transplant-related complications. If the disease in question is rare and slowly developing like pseudomyxoma peritonei
Ebbe Billmann Thorgersen, Espen Melum, Trine Folseraas, Stein Gunnar Larsen, Pål Dag Line   +4 more
doaj   +1 more source